Cachet Pharmaceuticals Pvt. Ltd. Cachet Pharmaceuticals was founded in 1978, what have been your main achievements? We started as a manufacturing company. In the early 1990s we started our own marketing and since then we have grown progressively and we are proud to say that today we are nearly 200 crores company with a…
India Since the company’s foundation in 1993, Hetero has clearly come a long way. What were the key success factors at that time, which laid the groundwork of a successful company? First of all, I am a scientist by background, and before founding Hetero I had been working at Dr. Reddy’s…
Hedef Alliance Turkey You are among the youngest GM’s of the top 200 companies in Turkey. What factors would you attribute to the rapid advancement of your career? I would say that there are several underlying factors that led to my rapid advancement. One factor influenced my choice of industry relates to my…
PHAREX HealthCorp Mr. Agana, you have been in Pharex HealthCorp for more than twenty years. Can you give to our readers an overview of Pharex and what have been the main achievements of the company that you are most proud of? Pharex is actually short for Pharmaceutical Excellence, which is something we…
Boehringer Ingelheim Mexico You arrived to the position of Boehringer Ingelheim Mexico’s General Director in 2010, what are some of the most exciting milestones and achievements you have presided over during this time? I’ve been in the company for 18 years, and came back from Germany in 2010 to become the company’s first…
The Government Pharmaceutical Organization (G Dr. Witit, when we interviewed your predecessor in 2006, we talked about the vital role and leading position GPO plays in the Thai pharmaceutical industry and the company’s investments in manufacturing facilities to improve access and affordability of drugs. What have been some of the most important milestones since you…
IMS Health Turkey Before we start with the interview I noticed that previously you were in charge of other regions aside from turkey. Is that still the case? If not why did IMS decide to separate Turkey from these regions ? Every third or fourth year, according to the growth of each country…
Herrington & Sutcliffe LLP - Hong Kong This interview was conducted with Christopher Stephens, managing partner of Orrick, Herrington & Sutcliffe’s Asia offices with supporting responses from Xiang Wang, lead partner of the firm’s IP pracitce as well as Patricia Thayer, life sciences specialist in IP litigation and counseling. Could you provide a brief introduction to Orrick,…
IMS Health Chile IMS was recently acquired by two investment funds, how has this affected the operations of the company and what changes did it bring in the Chilean context? So far, the acquisition has been beneficial for our Chilean operations. We expect bigger transformations to take place starting January 1st 2011, and…
The Balloch Group What initially attracted you to China and what kept you here over the years? I initially became interested in China during university where I studied the country and wrote a masters thesis on China. This was during the Cultural Revolution so it wasn’t easy to come to China in those…
Boehringer Ingelheim Chile What have been Boehringer Ingelheim’s major milestones and achievements since your establishment in Chile? Chile, in the regional context, represents a very important market with a solid evolution in terms of sales. For our company, on a regional scale, the country has been growing above the average rate of 15.6%…
China MSD China’s Michel Vounastos gives his initial impressions of the opportunities and challenges inherent in the Chinese healthcare market, and highlights how MSD’s offerings are able to address specific gaps in the country. You just arrived in China in February. The country managers we’ve met have all been here for…
See our Cookie Privacy Policy Here
